Diagnostic validation and prognostic significance of the Malnutrition-Inflammation Score in nondialyzed chronic kidney disease patients - PubMed (original) (raw)

doi: 10.1093/ndt/gfu380. Epub 2014 Dec 18.

Affiliations

PMID: 25523451
DOI: 10.1093/ndt/gfu380

Diagnostic validation and prognostic significance of the Malnutrition-Inflammation Score in nondialyzed chronic kidney disease patients

Fernanda C Amparo et al. Nephrol Dial Transplant. 2015 May.

Abstract

Background: Malnutrition and inflammation are highly prevalent and intimately linked conditions in chronic kidney disease (CKD) patients that lead to a state of protein-energy wasting (PEW), the severity of which can be assessed by the Malnutrition-Inflammation Score (MIS). Here, we applied MIS and validated, for the first time, its ability to grade PEW and predict mortality in nondialyzed CKD patients.

Methods: We cross-sectionally evaluated 300 CKD stages 3-5 patients [median age 61 (53-68) years; estimated glomerular filtration rate 18 (12-27) mL/min/1.73 m(2); 63% men] referred for the first time to our center. Patients were followed during a median 30 (18-37) months for all-cause mortality.

Results: A worsening in MIS scale was associated with inflammatory biomarkers increase (i.e. alpha-1 acid glycoprotein, fibrinogen, ferritin and C-reactive protein) as well as a progressive deterioration in various MIS-independent indicators of nutritional status based on anthropometrics, dynamometry, urea kinetics and bioelectric impedance analysis. A structural equation model with two latent variables (assessing simultaneously malnutrition and inflammation factors) demonstrated good fit to the observed data. During a follow-up, 71 deaths were recorded; patients with higher MIS were at increased mortality risk in both crude and adjusted Cox models.

Conclusions: MIS appears to be a useful tool to assess PEW in nondialyzed CKD patients. In addition, MIS identified patients at increased mortality risk.

Keywords: acute phase response; outcomes; renal disease; undernutrition; uremia.

PubMed Disclaimer

Cited by

Association between Body Mass Index and Renal Outcomes Modified by Chronic Kidney Disease and Anemia: The Obesity Paradox for Renal Outcomes.
Hung CC, Yu PH, Niu SW, Kuo IC, Lee JJ, Shen FC, Chang JM, Hwang SJ. Hung CC, et al. J Clin Med. 2022 May 15;11(10):2787. doi: 10.3390/jcm11102787. J Clin Med. 2022. PMID: 35628912 Free PMC article.
Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: "Can the Promise Be Kept?".
Crugliano G, Serra R, Ielapi N, Battaglia Y, Coppolino G, Bolignano D, Bracale UM, Pisani A, Faga T, Michael A, Provenzano M, Andreucci M. Crugliano G, et al. Int J Mol Sci. 2021 Nov 22;22(22):12590. doi: 10.3390/ijms222212590. Int J Mol Sci. 2021. PMID: 34830468 Free PMC article. Review.
Predictive Value of HbA1c and Metabolic Syndrome for Renal Outcome in Non-Diabetic CKD Stage 1-4 Patients.
Hung CC, Zhen YY, Niu SW, Lin KD, Lin HY, Lee JJ, Chang JM, Kuo IC. Hung CC, et al. Biomedicines. 2022 Aug 2;10(8):1858. doi: 10.3390/biomedicines10081858. Biomedicines. 2022. PMID: 36009406 Free PMC article.
Assessment of nutritional status in the maintenance of haemodialysis patients: a cross-sectional study from Palestine.
Omari AM, Omari LS, Dagash HH, Sweileh WM, Natour N, Zyoud SH. Omari AM, et al. BMC Nephrol. 2019 Mar 15;20(1):92. doi: 10.1186/s12882-019-1288-z. BMC Nephrol. 2019. PMID: 30876391 Free PMC article.
Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.
Besarab A, Chernyavskaya E, Motylev I, Shutov E, Kumbar LM, Gurevich K, Chan DT, Leong R, Poole L, Zhong M, Saikali KG, Franco M, Hemmerich S, Yu KH, Neff TB. Besarab A, et al. J Am Soc Nephrol. 2016 Apr;27(4):1225-33. doi: 10.1681/ASN.2015030241. Epub 2015 Oct 22. J Am Soc Nephrol. 2016. PMID: 26494833 Free PMC article. Clinical Trial.

Diagnostic validation and prognostic significance of the Malnutrition-Inflammation Score in nondialyzed chronic kidney disease patients - PubMed (original) (raw)